Use of replication-deficient poxvirus vector to boost CD4+T cell immune response to antigen
Details for Australian Patent Application No. 2001286109 (hide)
International Classifications
Event Publications
27 May 2004 Change of Name(s) of Applicant(s), Section 104
Oxxon Pharmaccines Limited The name of the applicant has been changed to Oxxon Therapeutics Limited 2002
14 December 2006 Application Accepted
Published as AU-B-2001286109
19 April 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser